Please login to the form below

Not currently logged in

Ad campaign to launch MS Week 08

The UK Multiple Sclerosis society has kicked off MS Week 2008 with a new ad campaign designed at raising awareness of disease management
The UK Multiple Sclerosis (MS) society has kicked off MS Week 2008 with a new ad campaign designed at raising awareness of disease management.

Four adverts will be run in the UK during the disease awareness week and will use the experiences of those affected by MS to convey the society's message. Using the words and images of disease sufferers, the campaign has been designed to inform people about the MS Society and how to better manager their disease.

MS Society chief executive, Simon Gillespie, said: "This MS Week, we want people to pick up the phone, get online, speak to their local MS Society branch and find out what they can do to actively manage their condition."

"People with MS shouldn't make themselves invisible to the health and social care system. It's your right to expect the best possible care and support and the Society is here to help," he added.

MS is one of the most common neurological disorders affecting an estimated 85,000 people and interferes with signals between the brand and body. Patients can experience symptoms such as loss of mobility, sight and can be cause fatigue, depression and cognitive problems.

Harriet form London, one of the people featured in the adverts, said: "I have found great support in using he MS Society's online forums and through the campaign I wanted to show that being diagnosed with MS is not the need of the world, there is life after MS. Since being diagnosed Iëve done so much to be proud of."

21st April 2008


Featured jobs

Subscribe to our email news alerts


Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...